Experience on switching trientine formulations in Wilson disease: Efficacy and safety after initiation of TETA 4HCl as substitute for TETA 2HClIsabelle Mohr, Karl Heinz Weiss, Müzeyyen Morgil et al.|Journal of Gastroenterology and Hepatology|2022Cited by 10
Efficacité et tolérance de deux sels de trientine dans le traitement de la maladie de WilsonFrance Woimant, Aurélia Poujois, Mickaël Alexandre Obadia et al.|Revue Neurologique|2021Cited by 0